Buy or sell Jasper Therapeutics stock pre IPO via an EquityZen fund
Jasper Therapeutics Stock
Jasper Therapeutics is a biotechnology company focused on enabling safer conditioning and therapeutic
About Jasper Therapeutics Stock
Jasper is a biotechnology company focused on enabling safer conditioning agents to allow for expanded use of curative therapy with stem cell transplants and gene therapies. Jasper’s lead compound, JSP191, is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients undergoing a stem cell transplant.
Co-Founder & Vice President Operations & Program Management
Co-Founder & Member Board of Directors
Judith Shizuru M.D.